Glide Technologies snaps up $4 mln
Glide Technologies, a drug developer, has closed $4 million in funding. Glide's investor base includes Invesco Perpetual, Oxford Technology Venture Capital Trusts, Oxford Capital Partners and Hygea VCT.
1 February 2017•1 min read
